Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses

Abstract Background Cyathostomins are the most important and common parasitic nematodes of horses, with > 50 species known to occur worldwide. The frequent and indiscriminate use of anthelmintics has resulted in the development of anthelmintic resistance (AR) in horse nematodes. In this study we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ghazanfar Abbas, Abdul Ghafar, John Hurley, Jenni Bauquier, Anne Beasley, Edwina J. A. Wilkes, Caroline Jacobson, Charles El-Hage, Lucy Cudmore, Peter Carrigan, Brett Tennent-Brown, Charles G. Gauci, Martin K. Nielsen, Kristopher J. Hughes, Ian Beveridge, Abdul Jabbar
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/0f8af9ac6cad46628a8f57ae3d70390a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f8af9ac6cad46628a8f57ae3d70390a
record_format dspace
spelling oai:doaj.org-article:0f8af9ac6cad46628a8f57ae3d70390a2021-12-05T12:17:06ZCyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses10.1186/s13071-021-05103-81756-3305https://doaj.org/article/0f8af9ac6cad46628a8f57ae3d70390a2021-12-01T00:00:00Zhttps://doi.org/10.1186/s13071-021-05103-8https://doaj.org/toc/1756-3305Abstract Background Cyathostomins are the most important and common parasitic nematodes of horses, with > 50 species known to occur worldwide. The frequent and indiscriminate use of anthelmintics has resulted in the development of anthelmintic resistance (AR) in horse nematodes. In this study we assessed the efficacy of commonly used anthelmintics against cyathostomins in Australian thoroughbred horses. Methods Two drug efficacy trials per farm were conducted on two thoroughbred horse farms in the state of Victoria, Australia. In the first trial, the horses on Farm A were treated with single and combinations of anthelmintics, including oxfendazole (OFZ), abamectin (ABM), abamectin and morantel (ABM + MOR), moxidectin (MOX) and oxfendazole and pyrantel (OFZ + PYR), at the recommended doses, whereas the horses on Farm B only received MOX, at the recommended dose. The faecal egg count reduction test (FECRT) was used to determine the efficacy and egg reappearance period (ERP) of anthelmintics. Based on the results of the first trial, the efficacies of MOX and a combination of ABM + MOR were reassessed to confirm their activities against cyathostomins. Results Of the five anthelmintic products tested on Farm A, resistance against OFZ, ABM and OFZ + PYR was found, with efficacies of − 41% (− 195% lower confidence limit [LCL]), 73% (60% LCL) and 82% (66% LCL) at 2 weeks post-treatment, respectively. The FECRT showed high efficacies of MOX and ABM + MOR (100%) at 2 week post-treatment and shortened ERPs for these anthelmintics (ABM + MOR: 4 weeks; MOX: 5 weeks). Resistance to MOX was found on Farm B, with a reduced efficacy of 90% (70% LCL) and 89% (82% LCL) at 2 weeks post-treatment in trials one and two, respectively. Conclusions This study provides the first evidence of MOX- and multidrug-resistant (ABM and combinations of anthelmintics) cyathostomins in Australia and indicates the need for continuous surveillance of the efficacy of currently effective anthelmintics and large-scale investigations to assess the ERP for various anthelmintics. Graphical AbstractGhazanfar AbbasAbdul GhafarJohn HurleyJenni BauquierAnne BeasleyEdwina J. A. WilkesCaroline JacobsonCharles El-HageLucy CudmorePeter CarriganBrett Tennent-BrownCharles G. GauciMartin K. NielsenKristopher J. HughesIan BeveridgeAbdul JabbarBMCarticleAustralian thoroughbred horsesCyathostominsEgg reappearance periodMoxidectinResistanceFECRTInfectious and parasitic diseasesRC109-216ENParasites & Vectors, Vol 14, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Australian thoroughbred horses
Cyathostomins
Egg reappearance period
Moxidectin
Resistance
FECRT
Infectious and parasitic diseases
RC109-216
spellingShingle Australian thoroughbred horses
Cyathostomins
Egg reappearance period
Moxidectin
Resistance
FECRT
Infectious and parasitic diseases
RC109-216
Ghazanfar Abbas
Abdul Ghafar
John Hurley
Jenni Bauquier
Anne Beasley
Edwina J. A. Wilkes
Caroline Jacobson
Charles El-Hage
Lucy Cudmore
Peter Carrigan
Brett Tennent-Brown
Charles G. Gauci
Martin K. Nielsen
Kristopher J. Hughes
Ian Beveridge
Abdul Jabbar
Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
description Abstract Background Cyathostomins are the most important and common parasitic nematodes of horses, with > 50 species known to occur worldwide. The frequent and indiscriminate use of anthelmintics has resulted in the development of anthelmintic resistance (AR) in horse nematodes. In this study we assessed the efficacy of commonly used anthelmintics against cyathostomins in Australian thoroughbred horses. Methods Two drug efficacy trials per farm were conducted on two thoroughbred horse farms in the state of Victoria, Australia. In the first trial, the horses on Farm A were treated with single and combinations of anthelmintics, including oxfendazole (OFZ), abamectin (ABM), abamectin and morantel (ABM + MOR), moxidectin (MOX) and oxfendazole and pyrantel (OFZ + PYR), at the recommended doses, whereas the horses on Farm B only received MOX, at the recommended dose. The faecal egg count reduction test (FECRT) was used to determine the efficacy and egg reappearance period (ERP) of anthelmintics. Based on the results of the first trial, the efficacies of MOX and a combination of ABM + MOR were reassessed to confirm their activities against cyathostomins. Results Of the five anthelmintic products tested on Farm A, resistance against OFZ, ABM and OFZ + PYR was found, with efficacies of − 41% (− 195% lower confidence limit [LCL]), 73% (60% LCL) and 82% (66% LCL) at 2 weeks post-treatment, respectively. The FECRT showed high efficacies of MOX and ABM + MOR (100%) at 2 week post-treatment and shortened ERPs for these anthelmintics (ABM + MOR: 4 weeks; MOX: 5 weeks). Resistance to MOX was found on Farm B, with a reduced efficacy of 90% (70% LCL) and 89% (82% LCL) at 2 weeks post-treatment in trials one and two, respectively. Conclusions This study provides the first evidence of MOX- and multidrug-resistant (ABM and combinations of anthelmintics) cyathostomins in Australia and indicates the need for continuous surveillance of the efficacy of currently effective anthelmintics and large-scale investigations to assess the ERP for various anthelmintics. Graphical Abstract
format article
author Ghazanfar Abbas
Abdul Ghafar
John Hurley
Jenni Bauquier
Anne Beasley
Edwina J. A. Wilkes
Caroline Jacobson
Charles El-Hage
Lucy Cudmore
Peter Carrigan
Brett Tennent-Brown
Charles G. Gauci
Martin K. Nielsen
Kristopher J. Hughes
Ian Beveridge
Abdul Jabbar
author_facet Ghazanfar Abbas
Abdul Ghafar
John Hurley
Jenni Bauquier
Anne Beasley
Edwina J. A. Wilkes
Caroline Jacobson
Charles El-Hage
Lucy Cudmore
Peter Carrigan
Brett Tennent-Brown
Charles G. Gauci
Martin K. Nielsen
Kristopher J. Hughes
Ian Beveridge
Abdul Jabbar
author_sort Ghazanfar Abbas
title Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
title_short Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
title_full Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
title_fullStr Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
title_full_unstemmed Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses
title_sort cyathostomin resistance to moxidectin and combinations of anthelmintics in australian horses
publisher BMC
publishDate 2021
url https://doaj.org/article/0f8af9ac6cad46628a8f57ae3d70390a
work_keys_str_mv AT ghazanfarabbas cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT abdulghafar cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT johnhurley cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT jennibauquier cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT annebeasley cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT edwinajawilkes cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT carolinejacobson cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT charleselhage cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT lucycudmore cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT petercarrigan cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT bretttennentbrown cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT charlesggauci cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT martinknielsen cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT kristopherjhughes cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT ianbeveridge cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
AT abduljabbar cyathostominresistancetomoxidectinandcombinationsofanthelminticsinaustralianhorses
_version_ 1718372058536083456